Comparative efficacy and predictive value of fixed combination of amlodipine and angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in patients with coronary heart disease, post-infarction cardiosclerosis and hypertension

Código QR

Comparative efficacy and predictive value of fixed combination of amlodipine and angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in patients with coronary heart disease, post-infarction cardiosclerosis and hypertension

The aim of the work – to analyze the effectiveness of a fixed combination of amlodipine and angiotensin-converting enzyme (ACE) inhibitor (lisinopril) or angiotensin II receptor blocker (valsartan) in patients with coronary heart disease (CHD), post-infarction cardiosclerosis (PIC), arterial hyperte...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	M. M. Dolzhenko, S. A. Bondarchuk
Formato:	article
Lenguaje:	EN RU UK
Publicado:	Zaporozhye State Medical University 2021
Materias:	combination drug therapy ace inhibitor amlodipine angiotensin 2 receptor blocker coronary heart disease post-cardiac cardiosclerosis combination drug blood pressure Medicine R
Acceso en línea:	https://doaj.org/article/384864df5d914ec78f431ca6ec6d57e1
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage
por: Zhang C, et al.
Publicado: (2021)

Improved Histoarchitectural Changes with Angiotensin Receptor Blockers in Early Testicular and Cauda Toxicity in Rats
por: Faddladdeen,Khadija Abduljalil, et al.
Publicado: (2019)

Use of angiotensin receptor – neprilysin inhibitors in heart failure: a paradigm shift
por: M. O.E. Irhuma, et al.
Publicado: (2016)

Effect of Angiotensin Receptor Blocker and Angiotensin Converting Enzyme Inhibitor on Kidney Function and Blood Potassium Level in Indonesian Type 2 Diabetes Mellitus with Hypertension: A Three-Month Cohort Study
por: Puspita FM, et al.
Publicado: (2021)

Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers: Anti-arrhythmic Drug for Arrhythmogenic Right Ventricular Cardiomyopathy
por: Bin Tu, et al.
Publicado: (2021)

The role of renin-angiotensin system and angiotensin-converting enzyme 2 (ACE2) in the development and course of viral infection COVID-19 in patients with diabetes mellitus
por: O. K. Vikulova, et al.
Publicado: (2020)

SYNTHESIS, CHEMICAL IDENTIFICATION, DRUG RELEASE AND DOCKING STUDIES OF THE AMLODIPINE–CHITOSAN NANOBIOPOLYMER COMPOSITE
por: Ramirez-Tagle,Rodrigo, et al.
Publicado: (2021)

Impact of beta2-agonists, beta-blockers, and their combination on cardiac function in elderly male patients with chronic obstructive pulmonary disease
por: Zeng LH, et al.
Publicado: (2013)

Effect of telmisartan, angiotensin‐converting enzyme inhibition, or both, on proteinuria and blood pressure in dogs
por: Brittany L. Fowler, et al.
Publicado: (2021)

Protective Effects of Angiotensin Receptor Blockers on the Incidence of Dementia in Patients with Chronic Kidney Disease: A Population-Based Nationwide Study
por: Yi-Hsien Chen, et al.
Publicado: (2021)

Association between angiotensinogen (AGT), angiotensin-converting enzyme (ACE) and angiotensin-II receptor 1 (AGTR1) polymorphisms and COVID-19 infection in the southeast of Iran: a preliminary case-control study
por: Hamid Reza Kouhpayeh, et al.
Publicado: (2021)

Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells
por: Oghenemega Okoloko, et al.
Publicado: (2021)

Reply to Siniorakis et al., “COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure”
por: David S. Fedson, et al.
Publicado: (2020)

Finger Millet Ethanol Extracts Prevent Hypertension by Inhibiting the Angiotensin-Converting Enzyme Level and Enhancing the Antioxidant Capacity in Spontaneously Hypertensive Rats
por: Se Yeong Park, et al.
Publicado: (2021)

Drug Intake and Actinic Keratosis: A Case-Control Study
por: Andrea Sechi, et al.
Publicado: (2021)

The Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Advanced-Stage Diabetic Kidney Disease Taking Renin-Angiotensin System Blockers
por: Hirai K, et al.
Publicado: (2020)

Effects of different enantiomers of amlodipine on lipid profiles and vasomotor factors in atherosclerotic rabbits
por: Zhang Jing, et al.
Publicado: (2021)

Aspects of efficacy, safety and adherence to antihypertensive therapy with single pill combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with 2 and 3 grade of arterial hypertension in the Russian clinical study VICTORY II
por: Irina E. Chazova, et al.
Publicado: (2021)

SIMULTANEOUS QUANTITATION OF OLMESARTAN MEDOXOMIL AND AMLODIPINE BESYLATE IN COMBINED TABLETS USING HPLC
por: QUTAB,SYED SHANAZ, et al.
Publicado: (2009)

The place of fixed antihypertensive drugs in modern therapy of arterial hypertension
por: Tatiana V. Pinchuk, et al.
Publicado: (2021)

Resistencia antimicrobiana en Helicobacter pylori: aspectos clínicos y moleculares
por: Vallejos M,Cristián, et al.
Publicado: (2003)

Beneficial Effects of Angiotensin II AT1 Blocker on Cardiovascular Adverse Remodeling Due to Nitric Oxide Synthesis Blockade
por: Fernandes-Santos,Caroline, et al.
Publicado: (2006)

Usefulness of Combined Measurement of Serum Soluble IL-2R and Angiotensin-Converting Enzyme in the Detection of Uveitis Associated with Japanese Sarcoidosis
por: Ishihara M, et al.
Publicado: (2020)

COVID-19 and Diabetes: A Comprehensive Review of Angiotensin Converting Enzyme 2, Mutual Effects and Pharmacotherapy
por: Lingli Xie, et al.
Publicado: (2021)

Optimization of Personalized Amlodipine Dosing Strategies for Children Based on Pharmacokinetic Data from Chinese Male Adults and PBPK Modeling
por: Xiaolu Han, et al.
Publicado: (2021)

Sarcoma de Kaposi y VIH: Tratamiento antirretroviral y quimioterapia en 32 pacientes
por: Lasso B,Martín, et al.
Publicado: (2003)

Strong Association of Angiotensin Converting Enzyme-2 Gene Insertion/Deletion Polymorphism with Susceptibility to SARS-CoV-2, Hypertension, Coronary Artery Disease and COVID-19 Disease Mortality
por: Mohammad Muzaffar Mir, et al.
Publicado: (2021)

Cost-effectiveness of routine measuring of serum drug concentrations and anti-drug antibodies in treatment of rheumatoid arthritis patients with TNF-α blockers
por: Laine J, et al.
Publicado: (2016)

Organoprotecive effects of angiotensin II receptor blockers in patients with type 2 diabetes mellitus
por: Ivona Yanovna Yarek-Martynova, et al.
Publicado: (2010)

Interaction of Drugs Used for the Treatment of Cardiovascular Diseases
por: Galina N. Kovalskaya, et al.
Publicado: (2019)

Síndrome de degeneración combinada de la médula espinal y radiculopatía en dos pacientes por quimioterapia intratecal con metrotrexato y citarabina. Casos clínicos
por: Cartier R.,Luis, et al.
Publicado: (2018)

Loading Amlodipine on Diamond Nanoparticles: A Novel Drug Delivery System
por: Alawdi SH, et al.
Publicado: (2020)

Combination of inflammatory and amlodipine induced gingival overgrowth in a patient with cardiovascular disease
por: Mohan Kumar Pasupuleti, et al.
Publicado: (2013)

Implementation of the organoprotective properties of fixed combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with grade 2 and 3 hypertension in the Russian clinical study VICTORY II
por: Irina E. Chazova, et al.
Publicado: (2020)

Effect of short-acting b--blockers on heart rate and blood pressure in patients with acute coronary syndrome during percutaneous and coronary intervention
por: L Rasputina, et al.
Publicado: (2021)

Measurement of serum ACE status may potentially improve the diagnosis of SARS-CoV-2 infection
por: Gcinokwakhe D Ngcobo
Publicado: (2021)

Efficacy and safety of using a fixed-dose combination of azilsartan medoxomil and chlorthalidone in patients with diabetes mellitus
por: Juliya V. Zhernakova, et al.
Publicado: (2021)

Relationship of quadriceps muscle power and optimal shortening velocity with angiotensin-converting enzyme activity in older women
por: Kostka J, et al.
Publicado: (2017)

Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
por: Marco Rossato, et al.
Publicado: (2020)

Transcriptomic Signatures Predict Regulators of Drug Synergy and Clinical Regimen Efficacy against Tuberculosis
por: Shuyi Ma, et al.
Publicado: (2019)